FR
₹1,488.20
-14.80(-0.98%)
FREDUN₹1,488.20-0.98%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsFREDUN valuation summary
Fredun Pharmaceuticals Ltd trades at 53.5 times trailing earnings. Return on equity is 15.8% and return on capital employed is 21.5%. The dividend yield is 0.02%. That P/E equals an earnings yield of 1.9%. The median P/E across 102 listed Drug Manufacturers - Specialty & Generic companies is 35.6, so Fredun Pharmaceuticals Ltd trades at a 30% premium to that median.
| P/E | 53.5 |
|---|---|
| ROE | 15.8% |
| ROCE | 21.5% |
| Dividend yield | 0.02% |